Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ileostomy diarrhea.

Andrew W DuPont1, Joseph H Sellin

  • 1Division of Gastroenterology, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555-0764, USA.

Current Treatment Options in Gastroenterology
|January 21, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microbiota restoration therapies for recurrent <i>Clostridioides difficile</i> infection reach an important new milestone.

Therapeutic advances in gastroenterology·2024
Same author

Incomplete Intestinal Metaplasia of the Stomach Is more Related to Bile Reflux than Chronic Gastritis.

Annals of clinical and laboratory science·2023
Same author

Fecal microbiota transplantation in Parkinson's disease-A randomized repeat-dose, placebo-controlled clinical pilot study.

Frontiers in neurology·2023
Same author

Colonic Eosinophilia: Clinicopathologic Study of Paired Right and Left Colon Biopsies from 276 Patients.

Annals of clinical and laboratory science·2023
Same author

Intestinal IgA-Coated Bacteria in Healthy- and Altered-Microbiomes (Dysbiosis) and Predictive Value in Successful Fecal Microbiota Transplantation.

Microorganisms·2023
Same author

The Quick Sepsis-Related Organ Failure Assessment Score Is Prognostic of Pancreatitis Severity in Patients With Alcohol-Induced Pancreatitis.

Pancreas·2022
Same journal

Esophageal Disorders in the Older Adult.

Current treatment options in gastroenterology·2025
Same journal

Endobariatrics: a Still Underutilized Weight Loss Tool.

Current treatment options in gastroenterology·2023
Same journal

Management of Post Ablative Barrett's Esophagus: a Review of Current Practices and Look at Emerging Technologies.

Current treatment options in gastroenterology·2023
Same journal

Inflammatory Bowel Disease Therapy and Venous Thromboembolism.

Current treatment options in gastroenterology·2023
Same journal

Ileal Pouch-Anal Anastomosis in the Older Adult: a Review of Postoperative Outcomes and Pouchitis Treatment.

Current treatment options in gastroenterology·2023
Same journal

Celiac Disease in the Elderly.

Current treatment options in gastroenterology·2023
See all related articles

Ileostomy diarrhea significantly impacts quality of life, with treatment often based on empiric approaches due to limited therapeutic trials. Current management focuses on diet and medications like loperamide, with newer options needing further study.

Area of Science:

  • Gastroenterology
  • Surgical Patient Management

Background:

  • Ileostomy diarrhea is a common complication affecting patient quality of life.
  • A lack of well-designed therapeutic trials necessitates largely empiric treatment strategies.
  • Idiopathic ileostomy diarrhea, often following proctocolectomy with limited ileal resection, is prevalent.

Purpose of the Study:

  • To review current treatment approaches for ileostomy diarrhea.
  • To evaluate the efficacy and limitations of existing and emerging therapies.
  • To guide clinical decision-making in managing this condition.

Main Methods:

  • Review of existing literature on ileostomy diarrhea management.
  • Analysis of empiric treatment strategies, including dietary modifications and pharmacotherapy.

Related Experiment Videos

  • Evaluation of preliminary data on novel treatments like budesonide and oleic acid.

    • Main Results:

    • Empiric treatment typically starts with dietary evaluation and loperamide.
    • Escalation to more expensive treatments may increase side effect profiles.
    • Emerging therapies (budesonide, oleic acid) show promise but require further validation; surgical options are limited.

    Conclusions:

    • Current management of ileostomy diarrhea is largely empiric, prioritizing safety and cost-effectiveness.
    • Further research is essential to establish evidence-based guidelines for effective treatment.
    • The role of surgical interventions beyond revision remains uncertain.